Osaka, Japan

Kazuhiro Fuchibe

USPTO Granted Patents = 4 


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazuhiro Fuchibe: Innovator in Medicinal Chemistry

Introduction

Kazuhiro Fuchibe is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the body. With a total of 4 patents to his name, Fuchibe's work is recognized for its potential impact on the treatment of various diseases.

Latest Patents

Fuchibe's latest patents include a tricyclic spiro compound that serves as a medicinal agent for the prevention and/or treatment of diseases caused by EPreceptor activation. This innovative compound contains an active ingredient that exhibits antagonistic activity against the EPreceptor. The compound is represented by a specific general formula, and it may exist as a salt, an N-oxide, or a solvate, or as a prodrug of these forms. This medicinal component is crucial for addressing diseases linked to EPreceptor activation.

Career Highlights

Kazuhiro Fuchibe is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to creating effective medicinal agents that can improve patient outcomes.

Collaborations

Fuchibe collaborates with notable colleagues, including Masaki Asada and Kousuke Tani. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.

Conclusion

Kazuhiro Fuchibe stands out as a key figure in medicinal chemistry, with a focus on developing compounds that can significantly impact healthcare. His contributions through patents and collaborations reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…